|Articles|January 11, 2023
- Pharmaceutical Executive: January 2023
- Volume 43
- Issue 01
Pharmaceutical Executive, January 2023 Issue (PDF)
Advertisement
Articles in this issue
over 3 years ago
Key Factors Attributing to a Successful Product Launchover 3 years ago
Closing the Digital Gap: FDA’s Oversight of Social Mediaover 3 years ago
Sales-Rep Compensation: Adding Long-Term Incentives to Mixover 3 years ago
Co-creating New Innovationsover 3 years ago
The Potential Impact of the IRAover 3 years ago
Patient Hubs Continue Growthover 3 years ago
Social Media’s Complex Climbover 3 years ago
Industry Workforce Seeks Clarityover 3 years ago
Cybersecurity Threats & PharmaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
2
Reading Between the Lines: Closing the T1D Misdiagnosis Gap
3
The New Healthy Aging Imperative and What It Means for Pharma
4
Pharmaceutical Executive Daily: FDA Clears Trodelvy for First-Line Metastatic Triple-Negative Breast Cancer
5